Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported, Synergy CHC Corp. (the “Company”) and certain of its subsidiaries filed voluntary petitions for relief under chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Columbia, on September 4, 2026 (the “Bankruptcy Filing”). On September 11, 2026, the Company received a letter (the “Delisting Notice”) from the staff of th…

Chief Restructuring Officer — Lauren P. Berret: The filing discloses the external hiring of a Chief Restructuring Officer in connection with a Chapter 11 bankruptcy filing, which is a significant management change but not a departure.

Bankruptcy or Receivership. On September 4, 2026, Synergy CHC Corp. (the “Company”) filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Columbia (the “Bankruptcy Court”). The chapter 11 case is captioned In re Synergy CHC Corp. , Case No. 26-465-ELG. As a result of the chapter 11 filing, the Company’s assets became subject to the jurisdiction of the Bankruptcy Court. The…

Triggering Events That Accelerate or Increase a Direct Financial Obligation On August 25, 2026, Synergy CHC Corp. (the “Company”) received a Notice of Acceleration (the “Acceleration Notice”) from ACP Agency, LLC (“ACP”), as administrative agent and collateral agent under the Company’s Term Loan Credit Agreement, dated as of May 30, 2025, as amended (the “Credit Agreement”). The Acceleration Notice states that, following the Events of Default previously disclosed by the Company in its Current…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 20, 2026, Synergy CHC Corp. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed…

Triggering Events That Accelerate or Increase a Direct Financial Obligation On August 11, 2026, Synergy CHC Corp. (the “Company”) received a notice of default (the “Default Notice”) from ACP Agency, LLC, as administrative agent and collateral agent (“ACP”), under the Company’s Term Loan Credit Agreement, dated as of May 30, 2025 (as amended, the “Credit Agreement”). In the Default Notice, ACP asserted that an Event of Default occurred under the Credit Agreement as a result of the Company’s fa…

The filing discloses an amendment to an equity incentive plan rather than a change in directors or officers.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 15, 2026, Synergy CHC Corp. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listi…

of this Current Report on Form 8-K and the press release furnished as Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Entry into a Material Definitive Agreement. On May 8, 2026, Synergy CHC Corp. (the “Company”) entered into an equity purchase agreement (the “Purchase Agreement”) with Hudson Global Ventures, LLC (the “Investor”), pursuant to which the Company has the right, but not the obligation, to direct the Investor to purchase up to $36,000,000 of the Company’s common stock, par value $0.00001 per share (“Common Stock”), subject to satisfaction of certain terms and conditions set forth in the Purchase A…

Unregistered Sales of Equity Securities. In connection with the Second Amendment, on March 24, 2026 the Company issued a common stock purchase warrant (the “Lender Warrant”) to Acme Credit Partners Fund I, LP (the “Holder”), a lender under the Credit Agreement. The Lender Warrant provides the Holder the right to purchase 3,000,000 shares of the Company’s common stock at an exercise price of $0.00001 per share. The Lender Warrant has a ten-year term and becomes exercisable upon the occurrence…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. The information under

Entry into a Material Definitive Agreement. On March 24, 2026, Synergy CHC Corp. (the “Company”) entered into a second amendment (the “Second Amendment”) to its term loan credit agreement, dated May 30, 2025 (as previously amended, the “Credit Agreement”, and as amended by the Second Amendment, the “Amended Credit Agreement”), with ACP Agency, LLC (“ACP”), as administrative agent and collateral agent, and the lenders party thereto. The Second Amendment amends certain provisions of the Credit…

of this Current Report on Form 8-K and the press release furnished as Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Director — Scott Woodburn: The director resigned to accept an internal executive role (Head of Strategic Partnerships) and was immediately replaced by a new director, indicating an orderly internal transition rather than a loss of talent.

Entry Into a Material Definitive Agreement. On August 27, 2025 (the “Closing Date”), Synergy CHC Corp. (the “Company”) sold an aggregate of 1,750,000 shares of the Company’s common stock, par value $0.00001 per share (the “Common Stock”), at a price to the public of $2.50 per share (the “Offering”), pursuant to that certain Underwriting Agreement, dated August 25, 2025 (the “Underwriting Agreement”), between the Company and Bancroft Capital, LLC, as representative (the “Representative”) of th…

of this Current Report on Form 8-K and the press release furnished as Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

The filing discloses an amendment to an equity incentive plan to increase share availability, which is a compensatory arrangement rather than a management departure or appointment.

Unregistered Sales of Equity Securities. On May 29, 2025, Synergy CHC Corp. (the “Company”) satisfied $12,713,858 of Company debt, previously owed to Knight Therapeutics International S.A. (“Knight”), through a combination of (i) a $10,000,000 cash repayment, (ii) an early payment discount of $1,213,858 and (iii) a conversion of $1,500,000 into equity (the “Equity Conversion”). On June 11, 2025 (the “Initial Exercise Date”), the Company issued a pre-funded common stock purchase warrant (the “…

Other Events. On June 4, 2025, the Company issued a press release regarding the closing of the Credit Agreement. A copy of the press release is attached as Exhibit 99.1 hereto.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. The information under

Entry into a Material Definitive Agreement. On May 30, 2025, Synergy CHC Corp. (the “Company”) entered into a term loan credit agreement (the “Credit Agreement”) with ACP Agency, LLC (“ACP”). The Credit Agreement consists of a $15.0 million term loan (the “Term Loan”), up to $2.5 million in a committed delayed draw facility (the “Delayed Draw Facility”), and up to $2.5 million in an uncommitted term loan incremental facility (the “Incremental Facility”), which facilities are secured by all of…

of this Current Report on Form 8-K and the press release furnished as Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

CFO — Jaime Fickett: The company appointed its Interim CFO to the permanent CFO role, representing an internal promotion and stabilization of the finance leadership.

of this Current Report on Form 8-K and the press release furnished as Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.